Health insurers pledge to simplify prior approval requirements

Published 23/06/2025, 20:18
© Reuters.

Investing.com - U.S. health secretary Robert F. Kennedy Jr. secured commitments from major health insurers Monday to streamline their prior authorization processes for medications and medical services.

The Department of Health and Human Services announced that Kennedy and Centers for Medicare and Medicaid Services Administrator Mehmet Oz met with representatives from several leading insurance providers to discuss simplification efforts. The meeting included executives from UnitedHealth Group Inc’s (NYSE:UNH) UnitedHealthcare, CVS Health Corp’s (NYSE:CVS) Aetna, Cigna Group (NYSE:CI), Humana Inc (NYSE:HUM), Blue Cross Blue Shield Association and Kaiser Permanente.

Prior authorization requirements, which mandate that healthcare providers obtain insurer approval before certain treatments or medications are covered, have long been criticized for creating administrative burdens and potentially delaying patient care.

During Monday’s meeting, the insurers pledged to implement additional measures to simplify these requirements, though specific details of these commitments were not outlined in the HHS statement.

The discussion represents part of the administration’s broader efforts to address healthcare administrative complexities that can impact both providers and patients throughout the U.S. healthcare system.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.